ÂÜÀòÂÒÂ×

Dr. Bergmeier is an Associate Professor of Biochemistry and Biophysics and a member of the Blood Research Center at University of North Carolina Chapel Hill. Wolfgang Bergmeier, PhD, is a biomedical researcher working in the fields of signal transduction, platelet biology, and hemostasis and thrombosis. His lab identified the small GTPase Rap1 and its regulators as a unique Rheostat for platelet reactivity, both in circulation and at sites of vascular injury. His ongoing work focuses on a better understanding of the Rap1 signaling pathway in platelets and megakaryocytes, and the implementation of his findings for the development of improved anti-platelet therapies.

In 2007, he moved to Thomas Jefferson University in Philadelphia where he became an Assistant Professor of Medicine and a member of the Cardeza Foundation for Hematologic Research. During his time in Philadelphia, he built an externally funded research program that investigates signaling transduction pathways critical for platelet function in hemostasis. For his postdoctoral studies, Dr. Bergmeier joined the laboratory of Dr. Denisa Wagner at Harvard Medical School (HMS). In 2004 he was promoted to Instructor of Pathology at the HMS. During his time there, Dr. Bergmeier studied the molecular mechanisms leading to platelet damage during extended storage and to platelet adhesion at sites of vascular injury.

He studied biology at the University of Regensburg in Germany and graduated from Witten-Herdecke University, Department of Molecular Oncology, in 2001.

Dr. Bergmeier has over 120 publications and 6 book chapters with an impressive H-Index of 52 based on the research he has conducted.